Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Other Gross PP&E Adjustments (2018 - 2023)

Rapid Therapeutic Science Laboratories' Other Gross PP&E Adjustments history spans 5 years, with the latest figure at $1.1 million for Q2 2023.

  • For Q2 2023, Other Gross PP&E Adjustments fell 10.61% year-over-year to $1.1 million; the TTM value through Jun 2023 reached $1.1 million, down 10.61%, while the annual FY2022 figure was $1.2 million, 55.03% up from the prior year.
  • Other Gross PP&E Adjustments for Q2 2023 was $1.1 million at Rapid Therapeutic Science Laboratories, up from $1.0 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $1.5 million in Q1 2022 and bottomed at $92979.0 in Q3 2020.
  • The 4-year median for Other Gross PP&E Adjustments is $912470.0 (2021), against an average of $888093.3.
  • The largest annual shift saw Other Gross PP&E Adjustments surged 678.58% in 2021 before it dropped 29.57% in 2023.
  • A 4-year view of Other Gross PP&E Adjustments shows it stood at $606740.0 in 2020, then surged by 30.16% to $789746.0 in 2021, then surged by 55.03% to $1.2 million in 2022, then decreased by 13.71% to $1.1 million in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Other Gross PP&E Adjustments are $1.1 million (Q2 2023), $1.0 million (Q1 2023), and $1.2 million (Q4 2022).